ResMEd, Koninklijke Philips N.V. and LivaNova PLC are dominating in the North America Anti-Snoring Devices and Snoring Surgery Market in 2020

North America Anti-Snoring Devices and Snoring Surgery Market is expected to grow with the CAGR of 9.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

 Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-anti-snoring-devices-and-snoring-surgery-market

North America anti-snoring devices and snoring surgery market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in North America anti-snoring devices and snoring surgery market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition and agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in March 2019, ResMed launched its resupply solution which provides timely PAP replacement supplies to patients who are suffering from sleep apnea. This would increase long-term adherence and improves satisfaction. This would help the company to gain further market in coming years. 

ResMed is the dominating player in North America anti-snoring devices and snoring surgery market. The other key players existing in the anti-snoring devices and snoring surgery market includes Apnea Sciences, The Pure Sleep Company, Foundation Consumer Healthcare, ZQuiet, GlaxoSmithKline plc, MPowrx, ZYPPAH, LivaNova PLC, Koninklijke Philips N.V., Fisher & Payker Healthcare Limited, Tomed GmbH, SomnoMed Inc., Airway Management, Meditas Ltd., Airavant among others.

North America Anti-Snoring Devices and Snoring Surgery Market ResMed:

ResMed is headquartered in California, U.S. and was founded in 1989. The company is engaged in manufacturing of medical devices that transform care for people with sleep apnea, COPD and other chronic diseases. The company deals in business segments such as sleep & respiratory care and software out of which sleep & respiratory care is the market focused segment. The company provides products under categories namely sleep apnea, portable oxygen and ventilation among which sleep apnea is the market focused category.

For instance,

  • In June 2019, ResMed exhibited medical research leadership and highlighted the prevalence of sleep apnea and the best practices available to diagnose and treat the disease at the Convention Center in the U.S. This leadership role would help the company to attract more customers for its innovative products and would boost the market.             

The company has presence across North America, South America, Europe, Asia-Pacific and Middle East and Africa which also generates revenue through various subsidiary companies such as Propeller Health (U.S.), Brightree LLC (Georgia), MatrixCare Inc. (U.S.), Inova Labs Inc. (U.S.), HEALTHcare first Inc. (U.S.) among others.

Koninklijke Philips N.V.:

Koninklijke Philips N.V. is headquartered in Amsterdam, the Netherlands and was founded in 1891. The company is leading health technology focused on improving people's health and well-being and enabling better outcomes across the health continuum from healthy living and prevention to diagnosis, treatment and home care. The company deals in business segments such as diagnostic and treatment, connected care and personal health out of which connected care is the market focused segment. The company provides products under categories namely advanced molecular nuclear imaging, breathing and respiratory care, hospital respiratory care, home respiratory care, radiation oncology, pathology and ultrasound among which home respiratory care is the market focused category.

For instance,

  • In September 2019, Koninklijke Philips N.V. announced the launch of the new product Philips NightBalance which is asleep position therapy device designed for patients who are suffering from obstructive sleep apnea (OSA). This new technology will raise the demand for such products in the market and would help the company to diversify its market.

The company has presence across North America, South America, Europe, Asia-Pacific and Middle East and Africa which also generates revenue through various subsidiary companies such as Saeco (Italy), Respironics Inc. (U.S.), Magnavox (U.S.), Lifeline Systems Company (U.S.), Dynalite (Australia) among others.

LivaNova PLC:

LivaNova PLC is headquartered in London, U.K. and was founded in 1987. The company is a global medical technology company engaged in cardiovascular and neuromodulation solutions. The company deals in business segments such as cardiopulmonary, heart valves, advanced circulatory support, cardiovascular and neuromodulation out of which neuromodulation is the market focused segment. The company provides products under categories namely cardiovascular and neuromodulation in which neuromodulation is the market focused category.  

For instance,

  • In December 2017, LivaNova PLC agreed to acquire the remaining outstanding interest in ImThera Medical, Inc. which is a privately held company focused on neuro-stimulation for the treatment of obstructive sleep apnea (OSA). The company manufacturer implantable devices that stimulate multiple tongue muscles via the hypoglossal nerve which opens the airway while a patient is screening.

The company has wide presence across North America, South America, Europe, Asia-Pacific and Middle East and Africa.